Moderna Inc
(XSWX:MRNA)
CHF
58.54
+0.73 (+1.26%)
Market Cap: 25.61 Bil
Enterprise Value: 22.45 Bil
PE Ratio: 0
PB Ratio: 3.93
GF Score: 62/100 Moderna Inc at Goldman Sachs Healthcare Conference Transcript
Jun 09, 2026 / 07:20PM GMT
Release Date Price:
CHF37.02
(-5.37%)
Salveen Richter
Goldman Sachs Group Inc - Analyst
Good afternoon, everyone. Thank you so much for joining us.
It's my pleasure to introduce Moderna.
With us, we have Jamey Mock, CFO. Jamey, thanks for joining us.
Jamey Mock
Moderna Inc - Chief Financial Officer
Thanks for having me.
Questions & Answers
Salveen Richter
Goldman Sachs Group Inc - Analyst
To start here, maybe frame for us how you see the company positioned today.
There's been an evolution, I think, with regard to the growth outlook for the commercial business, with the COVID and combination flu plus COVID vaccines, where you've gone to the point, I think, here of returning to this positive revenue growth cycle.
You have an opportunity set with your late-stage pipeline. What are you most focused on, when you look at this, from a strategy and execution standpoint, as we head into second half and beyond?
Jamey Mock
Moderna Inc - Chief Financial Officer
Yeah.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot